MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Clinical trial NCT00072930 · COMPLETED

Trial details

NCT number: NCT00072930
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-12-01
Primary completion: 2007-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.